Advertisement
Screener

Amphastar Pharmaceuticals, Inc. (AMPH) Cash Flow Breakdown

Amphastar Pharmaceuticals, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Amphastar Pharmaceuticals, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $156.12M came in.
  • Fiscal year ended 2025-12-31: from investing, $70.33M went out.
  • Fiscal year ended 2025-12-31: from financing, $67.42M went out.
  • Fiscal year ended 2025-12-31: change in cash, $18.57M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31$156.12M-$70.33M-$75.59M-$223.00K$6.22M$6.39M-$4.22M*$18.57M
2024-12-31$213.39M-$124.93M-$85.46M-$8.26M$18.43M$12.24M-$17.90M*$7.31M
2023-12-31$183.50M-$649.12M-$58.14M-$318.66M$845.00M$14.17M-$28.28M*-$11.80M
2022-12-31$89.18M-$32.78M-$39.91M-$1.78M$19.20M-$3.95M*$29.75M
2021-12-31$97.99M-$28.67M-$28.87M-$36.74M$70.00M-$1.16M$16.76M-$57.00M*$32.08M
2020-12-31$57.27M-$36.41M-$24.43M-$8.40M$6.28M$1.24M*$24.36M$18.96M
2019-12-31$41.76M-$50.53M-$22.29M-$6.43M$3.57M-$347.00K$7.76M$13.96M*-$12.65M
2018-12-31$38.19M-$42.18M-$25.05M-$5.71M$8.43M$347.00K$11.75M$35.23M*$20.74M
2017-12-31$39.21M-$36.89M-$30.75M-$9.71M$18.98M$19.10M-$5.34M*-$4.89M
2016-12-31$38.56M-$39.50M-$9.91M-$14.65M$10.20M$20.34M$863.00K$6.28M
2015-12-31$10.68M-$16.93M-$9.87M-$8.99M$6.79M$13.50M$806.00K*-$1.75M
2014-12-31$21.05M-$39.77M-$345.00K-$8.22M$26.50M-$15.00M*-$389.00K$38.02M-$1.11M-$7.35M*$14.24M
2013-12-31$31.04M-$18.30M-$199.00K-$2.15M-$5.00M*-$199.00K$55.00K-$647.00K-$1.23M*$3.37M
2012-12-31-$1.65M-$25.11M-$811.00K-$874.00K$24.71M*$333.00K-$120.00K-$3.52M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldNot split outChange in cash
2026-06-30$51.32M*$44.87M*-$45.21M*-$47.00K*$312.00K$1.41M*
2026-03-31$47.84M-$16.73M-$29.49M-$29.00K$1.85M-$2.54M*$762.00K
2025-12-31$32.86M*-$60.57M*-$20.52M*-$104.00K*$273.00K*$591.00K*$1.38M*
2025-09-30$52.58M*-$19.62M*-$4.85M*-$44.00K*$172.00K*$411.00K
2025-06-30$35.59M*-$625.00K*-$39.22M*-$37.00K*$4.13M*$3.32M$1.61M*
2025-03-31$35.08M$10.48M-$11.00M-$38.00K$1.64M$2.07M-$7.17M*$31.17M
2024-12-31$29.02M*-$35.68M*-$42.00M*-$115.00K*$4.87M*$1.84M*$1.57M*
2024-09-30$59.96M*-$34.59M*-$34.96M*-$41.00K*$9.51M*$3.33M-$657.00K*
2024-06-30$69.11M*-$69.90M*-$8.01M*-$25.00K*$4.00M-$6.68M*
2024-03-31$55.29M$15.24M-$98.00K$4.08M$3.07M-$20.63M*$56.85M
2023-12-31$23.86M*-$103.05M*$0.00*-$50.15M*$0.00*$2.16M*$912.00K*
2023-09-30$64.33M*-$31.15M*-$50.00M*-$200.07M*$345.00M*$2.28M-$10.59M*
2023-06-30$54.92M*-$508.58M*-$128.00K*-$67.46M*$8.35M$487.35M*
2023-03-31$40.38M-$6.33M-$8.02M-$968.00K$1.39M-$5.95M*$20.52M
2022-12-31$15.23M*-$229.00K*-$18.07M*-$128.00K*$800.00K*$1.24M*
2022-09-30$20.38M*-$15.26M*-$14.49M*-$522.00K*$1.48M
2022-06-30$2.81M*-$8.18M*-$6.12M*-$593.00K*$4.47M$1.25M*
2022-03-31$50.77M-$9.11M-$1.23M-$538.00K$12.45M-$6.04M*$46.27M
2021-12-31$40.44M*-$11.95M*-$13.44M*-$613.00K*$0.00*$0.00*$4.63M*
2021-09-30$2.57M*-$3.77M*-$6.09M*-$28.86M*-$387.00K*$3.95M$14.89M*
2021-06-30$32.16M*-$4.25M*-$5.56M*-$5.26M*$6.00M
2021-03-31$22.82M-$8.70M-$3.78M-$2.00M$2.17M-$3.02M*$7.33M
2020-12-31$16.89M*-$12.18M*-$3.39M*-$2.07M*$3.22M*$166.00K*$823.00K*$1.03M*
2020-09-30$8.81M*-$5.45M*-$4.33M*-$2.06M*$0.00*$367.00K*$3.19M
2020-06-30$30.09M*-$10.07M*-$5.76M*-$1.94M*$0.00*$19.09M$1.06M*
2020-03-31$1.48M-$8.72M-$10.95M-$2.33M$3.07M$1.25M-$2.49M*-$18.84M
2019-12-31$5.65M*-$7.35M*-$13.78M*-$1.61M*$0.00*$480.00K*$4.53M*
2019-09-30-$12.00M*-$18.62M*-$4.43M*-$1.60M*$0.00*$2.23M
2019-06-30$51.72M*-$9.67M*-$1.07M*-$1.56M*$1.11M
2019-03-31-$3.61M-$14.88M-$3.02M-$1.66M$3.94M$11.96M*-$7.24M
2018-12-31$9.52M*-$8.80M*-$2.61M*-$1.41M*$431.00K*$0.00*$7.71M*$12.80M*$17.60M*
2018-09-30$15.78M*-$12.88M*-$7.59M*-$1.46M*$0.00*$87.00K*$1.54M$25.23M*$20.66M*
2018-06-30$4.53M*-$11.77M*-$7.23M*-$1.42M*$650.00K$9.11M*-$6.48M*
2018-03-31$8.36M-$8.74M-$7.62M-$1.41M$1.86M-$3.65M*-$11.05M
2017-12-31$9.77M*-$10.13M*-$5.97M*-$1.33M*$0.00*$9.58M*-$3.07M*-$1.33M*
2017-09-30$2.47M*-$12.97M*-$7.59M*-$5.76M*$7.87M*$782.00K*-$15.62M*
2017-06-30$4.57M*-$7.83M*-$8.98M*-$1.28M*$8.64M$11.93M*$7.51M*
2017-03-31$22.40M-$5.96M-$8.20M-$1.34M$96.00K-$2.27M*$4.54M
2016-12-31$14.01M*-$7.11M*-$922.00K*-$4.68M*$0.00*$2.75M*$1.59M*$5.76M*
2016-09-30$1.30M*-$14.96M*-$796.00K*-$3.55M*$3.59M*-$100.00K*$14.33M-$62.00K*
2016-06-30$9.33M*-$8.01M*-$3.47M*-$1.36M*$2.88M*-$159.00K*$3.15M$3.33M*
2016-03-31$13.93M-$9.42M-$4.72M-$5.06M$3.73M-$1.08M$104.00K-$2.74M
2015-12-31$3.29M*-$4.46M*-$4.18M*-$5.02M*-$1.00K*$236.00K*$2.25M*$1.15M*-$4.61M*
2015-09-30$3.55M*-$3.70M*-$2.97M*-$1.45M*$0.00*-$116.00K*$816.00K-$3.78M*
2015-06-30$2.50M*-$3.72M*-$1.23M*-$1.33M*-$3.00K*-$169.00K*$9.53M$5.88M*
2015-03-31$1.34M-$5.04M-$1.49M-$1.19M$6.79M-$572.00K$910.00K$760.00K
2014-12-31$12.32M*-$9.93M*$140.00K*-$1.07M*$0.00*$0.00*-$130.00K*-$7.50M*-$5.05M*
2014-09-30$13.63M*-$3.13M*-$1.12M*$0.00*$0.00*$0.00*$8.80M*
2014-06-30$934.00K*-$21.92M*-$5.36M*-$25.00M*$571.00K$62.75M*$11.95M*
2014-03-31-$5.83M-$4.80M-$673.00K$10.00M*-$1.45M
2013-12-31$8.51M*-$3.17M*-$184.00K*-$701.00K*-$1.00M*$4.00K*-$1.82M*$1.64M*
2013-09-30$709.00K*-$5.08M*-$577.00K*$1.00M*$38.00K-$4.01M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
MANNKIND CORP (MNKD)United States$1.058B-30.41
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Jaguar Health, Inc. (JAGX)United States$1.184B
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87